AllNewsPhotosVideos
HGC019

Hdt Bio Corp., Photos

Hdt bio corp., Latest News

HGC019 is a mRNA based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with active support from NIH under The Indo-US Vaccine Action Program and Department of Biotechnology, India.
Read More